These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 343200)

  • 1. [Clinical trial of the new beta-blockader atenolol].
    Sánchez Cascos A; Gausi Gene C; Richart Martínez JA; De Rabago González P; Bros Caimari R; García Gallego F
    Rev Esp Cardiol; 1977; 30(5):545-8. PubMed ID: 343200
    [No Abstract]   [Full Text] [Related]  

  • 2. [Atenolol (Tenormin) in the treatment of angina pectoris].
    Haghfelt T; Pindborg T; Thayssen P
    Ugeskr Laeger; 1980 Sep; 142(38):2475-8. PubMed ID: 7003873
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of atenolol in angina pectoris of effort.
    Hernández-Cañero A; González A; Cardonne A; Pérez-Medina T; Garcia-Barreto D
    Cor Vasa; 1972; 20(2):99-103. PubMed ID: 4499921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of atenolol in angina.
    Sowton E
    Postgrad Med J; 1977; 53 Suppl 3():90-3. PubMed ID: 337273
    [No Abstract]   [Full Text] [Related]  

  • 5. Celiprolol and atenolol in angina--effects on left ventricular function.
    Dargie H; McLenachan JM; Wilson JT
    J Int Med Res; 1988; 16 Suppl 1():47A-51A. PubMed ID: 2906017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Timolol in long-term treatment of patients with angina pectoris].
    Keyriläinen O; Uusitalo A
    Duodecim; 1977; 93(24):1615-23. PubMed ID: 342233
    [No Abstract]   [Full Text] [Related]  

  • 7. [Atenolol in the treatment of angina pectoris].
    Bachmann M; Raeber E; Burckhardt D; Schwytzer F; Münch U; Kappenberger L; Nager F
    Schweiz Med Wochenschr; 1979 Dec; 109(47):1857-60. PubMed ID: 531563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy and tolerability of a cardioselective beta-blocking drug (atenolol) in the treatment of essential hypertension. A double blind study (author's transl)].
    Rengo F; Trimarco B; Petretta M; Ferrara N; Bonaduce D; Chiariello M; Condorelli M
    G Ital Cardiol; 1978; 8(8):861-7. PubMed ID: 359398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects of atenolol on the exercise symptoms of coronary patients. A double blind study (author's transl)].
    Bischoff K
    MMW Munch Med Wochenschr; 1981 Sep; 123(36):1337-40. PubMed ID: 6792528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once daily atenolol (Tenormine) in the treatment of angina pectoris. Observations on clinical efficacy, pharmacokinetics and pharmacodynamics.
    Majid PA; van der Vijgh WJ; de Feijter PJ; Wardeh R; van der Wall EE; Roos JP
    Eur J Cardiol; 1979 Jun; 9(6):419-35. PubMed ID: 381009
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutical comparison between atenolol and nifedipine in effort angina (author's transl)].
    Gruppillo P; Battaglia R; Masoni C; Maistrello I; Masoni A
    G Ital Cardiol; 1981; 11(12):2081-7. PubMed ID: 7049817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclothiazide and atenolol once daily in essential hypertension.
    Pitkäjärvi T
    Ann Clin Res; 1979 Feb; 11(1):1-8. PubMed ID: 378090
    [No Abstract]   [Full Text] [Related]  

  • 13. [Longterm therapy of angina pectoris patients with a new beta-receptor blocker (author's transl)].
    Schaumann HJ; Diekmann HJ; Neuss H; Stegaru B
    MMW Munch Med Wochenschr; 1976 Sep; 118(36):1123-5. PubMed ID: 9583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of bunitrolol (Ko 1366) in the therapy of angina pectoris].
    Maranhão MF; Rocha SW; Lopes M; Toledo MT; Furlan L; Hilú M; Pereira da Cunha G
    Arq Bras Cardiol; 1978 Apr; 31(2):143-7. PubMed ID: 28715
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical testing of a new beta blocking agent--atenolol--in hypertension].
    Hansson L; Henningsen NC; Jameson S; Karlberg BE; Westerlund A; Aberg H
    Lakartidningen; 1976 Aug; 73(34):2741-4. PubMed ID: 787700
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of atenolol and its clinical consequences in patients with angina pectoris.
    van der Vijgh WJ; Majid PA; de Feyter PJ; Wardeh R; van der Wall EE
    Int J Clin Pharmacol Ther Toxicol; 1980 Sep; 18(9):375-7. PubMed ID: 7005122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of chronic administration of atenolol on exercise tolerance in angina].
    Radice M; Antongiovanni GB; Corbetta G; Folli G
    Boll Soc Ital Cardiol; 1981; 26(11):1807-9. PubMed ID: 6758819
    [No Abstract]   [Full Text] [Related]  

  • 18. [Double-blind clinical study of timolol maleate in angina pectoris].
    Chapelle M; Senikies A; Witchitz S; Chiche P
    Coeur Med Interne; 1976; 15(4):587-93. PubMed ID: 798650
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy of atenolol in moderate-to-mild essential hypertension and in ischemic cardiopathy. Evaluation with the bicycle ergometer].
    Mellini M; Robutti A; Mattiauda C; Cavazzana G; Roych C; Sanfelici D; Baccino M; Reforzo F
    Clin Ter; 1983 Mar; 104(5):391-4. PubMed ID: 6851445
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic differences between atenolol and pindolol in asthmatic patients].
    Hellström PE; Salonen T
    Duodecim; 1979; 95(6):287-91. PubMed ID: 374041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.